Pro-Dex Inc (PDEX)

46.96 -2.59 (-5.23%) USD  |  NASDAQ  |  Nov 13, 16:00
47.38 +0.42 (+0.89%) After-Hours: 20:00
More

Pro-Dex Research and Development Expense (Quarterly): 0.843M for Sept. 30, 2024

Research and Development Expense (Quarterly) Chart

Historical Research and Development Expense (Quarterly) Data

View and export this data back to 1995. Upgrade now.
Date Value
September 30, 2024 0.843M
June 30, 2024 0.836M
March 31, 2024 0.76M
December 31, 2023 0.788M
September 30, 2023 0.805M
June 30, 2023 0.695M
March 31, 2023 0.713M
December 31, 2022 0.467M
September 30, 2022 0.929M
June 30, 2022 0.726M
March 31, 2022 0.658M
December 31, 2021 0.615M
September 30, 2021 0.98M
June 30, 2021 1.20M
March 31, 2021 1.104M
December 31, 2020 0.989M
September 30, 2020 1.091M
June 30, 2020 0.814M
March 31, 2020 0.62M
December 31, 2019 0.397M
September 30, 2019 0.484M
June 30, 2019 0.545M
March 31, 2019 0.603M
December 31, 2018 0.326M
September 30, 2018 0.408M
Date Value
June 30, 2018 0.448M
March 31, 2018 0.56M
December 31, 2017 0.478M
September 30, 2017 0.407M
June 30, 2017 0.386M
March 31, 2017 0.257M
December 31, 2016 0.278M
September 30, 2016 0.304M
June 30, 2016 0.375M
March 31, 2016 0.301M
December 31, 2015 0.264M
September 30, 2015 0.429M
June 30, 2015 0.359M
March 31, 2015 0.48M
December 31, 2014 0.444M
September 30, 2014 0.384M
June 30, 2014 0.361M
March 31, 2014 0.381M
December 31, 2013 0.364M
September 30, 2013 0.375M
June 30, 2013 0.43M
March 31, 2013 0.49M
December 31, 2012 0.464M
September 30, 2012 0.406M
June 30, 2012 0.513M

R&D Expense Definition

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (Quarterly) Range, Past 5 Years

0.397M
Minimum
Dec 2019
1.20M
Maximum
Jun 2021
0.8015M
Average
0.7965M
Median

Research and Development Expense (Quarterly) Benchmarks

Perspective Therapeutics Inc 9.275M
Retractable Technologies Inc 0.1991M
InfuSystems Holdings Inc --
Xtant Medical Holdings Inc 0.636M
Catheter Precision Inc 0.081M